We have more than 20 years experience operating in Japan and all Asia Pacific markets in a variety of industries including:  Consumer, Luxury goods, Pharmaceutical, Technology and industrial segments.

We have demonstrated ability to accelerate growth and to bring true strategic innovation to complex and competitive market places.

Our current investments include:

• Apivita (Japan)
• Recursion Pharmaceuticals (USA)
• Uwinloc (France)
• NuRep (USA)
• Intabio (USA)
• Beacon (Taiwan/China)